ArticleJournal of virology2022

A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.

Mengqi Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.